跳至主要内容
临床试验/NCT02498717
NCT02498717已完成不适用

Preliminary Efficacy and Cost-effectiveness Analysis of a Cold and Active Intermittent Compression Therapy Technique for Traumatic Calcaneus or Ankle Fractures

AdventHealth1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2015年6月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
AdventHealth
入组人数
55
试验地点
1
主要终点
Time until surgery/Time until discharge (LOS)

研究概览

简要总结

This study will examine the initial efficacy and cost-effectiveness of using the cryocompression therapy model both pre-operatively and post-operatively in patients that have recently suffered a traumatic calcaneus or ankle fracture compared to the standard pre-operative RICE therapy procedures.

详细描述

Initial research has shown that cryocompression therapy applied post-operatively has been effective in reducing recovery time and improving health and pain factors related to patient recovery. However, there has been limited research into how this translates into positive economic outcomes for both the hospital and the patient. In addition, it can be reasonably hypothesized that the use of the cryocompression therapy system before surgery will lead to an increased rate of reduction in swelling necessary to allow proper operative procedures to take place when compared to the standard ice and elevation (RICE) therapy techniques and cryocompression therapy applied only post-operatively. This should lead to decreased hospital costs and possible improved patient outcomes related to recovery.

Study Objectives This study will examine the initial efficacy and cost-effectiveness of using the cryocompression therapy model both pre-operatively and post-operatively in patients that have recently suffered a traumatic calcaneus or ankle fracture compared to the standard pre-operative RICE therapy procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Patients over 18 years of age
  • •Able to provide informed consent
  • •Recent calcaneus or ankle fracture requiring fixation
  • •Injury is determined (by physician) to be an isolated, closed, low-energy bimalleolar fracture

排除标准

  • •Unable to provide informed consent
  • •History of Dementia or mental instability
  • •No recent additional fractures (within one year) at or around injury site
  • •Persons with symptoms of any kind of psychosocial disorder
  • •Any condition that the clinician feels would contraindicate for the postoperative test or control treatments
  • •Any conditions that would contraindicate using the Game Ready
  • •If the patient is prevented from transfer to the OR due to reasons other than medically necessary

研究组 & 干预措施

Cryocompression (experimental)

Experimental

treatment using the GameReady cryotherapy system

干预措施: GameReady (Device)

RICE (control)

Active Comparator

Standard of Care procedures including ice and elevation.

干预措施: RICE (Other)

结局指标

主要结局

Time until surgery/Time until discharge (LOS)

时间窗: Measured from intake to time of surgery (days) and upon discharge from hospital (days). Estimated period of time to be up to 10 days until surgery and up to 7 days after surgery until discharge.

Reduction in length of stay (LOS) and time of effect (pre-/post-op)

Change in Swelling as measured by point of largest swollen area (tape measure)

时间窗: Measured at baseline and all follow-up assessments (2, 8, 16, & 24-weeks post-op)

Measured at circumference of swelling point

Total Narcotic Use as recorded on MR chart and Knee Pain Assessment

时间窗: Measured daily while inpatient (approx 2-3 days) and retroactively at all follow-up assessments (2, 8, 16, & 24-weeks post-op)

reported as yes/no and amount/type on assessment form

Change in Patient reported pain as measured on VAS and Knee Pain Assessment

时间窗: Reported at baseline, daily while inpatient (approx 2-3 days), and at all follow-up assessments (2, 8, 16, & 24-weeks post-op)

As reported by VAS scale

次要结局

  • Change in Quality of Life (QALY) as measured on QOL and SF-8(At baseline and all follow-up assessments (2, 8, 16, & 24-weeks post-op))

研究者

发起方
AdventHealth
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验